Evidence map›Paper›PMID 29528139›Full record

ArticleMolecular carcinogenesis2018

Associations between expression levels of nucleotide excision repair proteins in lymphoblastoid cells and risk of squamous cell carcinoma of the head and neck.

Peng Han, Hongliang Liu, Qiong Shi, Zhensheng Liu, Jesse D Troy, Walter T Lee, Jose P Zevallos, Guojun Li, Erich M Sturgis, Qingyi Wei

Abstract read
In one paragraph

Article in Molecular carcinogenesis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Peng HanDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.
Hongliang LiuDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.
Qiong ShiDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.
Zhensheng LiuDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.
Jesse D TroyDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.
Walter T LeeDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.
Jose P ZevallosDepartment of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri.
Guojun LiDepartments of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.ORCID 0000-0001-9505-1502
Erich M SturgisDepartments of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Qingyi WeiDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0002-3845-9445
Duke University · USThe University of Texas MD Anderson Cancer Center · USUniversity of North Carolina at Chapel Hill · US

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI JOHN N. NORTON · 1985 to 2026
$174.8M
Molecular Epidemiology of Head and Neck CancerR01ES011740 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2001 to 2012
$6.3M
Genotypes and Phenotypes of Apoptosis and Risk of Head and Neck CancerR01CA131274 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2009 to 2013
$3.0M
NCI NIH HHS P30 CA014236NCI NIH HHS R01 CA131274NIEHS NIH HHS R01 ES011740
6 · The paper itself

Abstract

Squamous cell carcinoma of head and neck (SCCHN) is one of the most common malignancies worldwide, and nucleotide excision repair (NER) is involved in SCCHN susceptibility. In this analysis of 349 newly diagnosed SCCHN patients and 295 cancer-free controls, we investigated whether expression levels of eight core NER proteins were associated with risk of SCCHN. We quantified NER protein expression levels in cultured peripheral lymphocytes using a reverse-phase protein microarray. Compared with the controls, SCCHN patients had statistically significantly lower expression levels of ERCC3 and XPA (P = 0.001 and 0.001, respectively). After dividing the subjects by controls' median values of expression levels, we found a dose-dependent association between an increased risk of SCCHN and low expression levels of ERCC3 (adjusted OR, 1.75, and 95% CI: 1.26-2.42; P

Indexed as

AdultAgedAged, 80 and overCarcinoma, Squamous CellCells, CulturedDNA-Binding ProteinsDNA HelicasesFemaleHead and Neck NeoplasmsHumansLymphocytesMaleMiddle AgedRisk AssessmentRisk FactorsXeroderma Pigmentosum Group A ProteinDNA-Binding ProteinsDNA HelicasesXeroderma Pigmentosum Group A ProteinXPBC-ERCC-3 proteinbiomarkerDNA repairhead and neck cancerNER pathwayprotein expression

Identifiers

PMID29528139
PMCPMC5930125
OpenAlexW2789393380

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.